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Although a network of transcription factors that speciﬁes neural crest identity in the ectoderm has been
deﬁned, expression of neural crest transcription factors does not guarantee eventual migration as a
neural crest cell. While much work has gone into determining regulatory relationships within the
transcription factor network, the ability of protein modiﬁcations like phosphorylation to modulate the
function of neural crest regulatory factors and determine when and where they are active also has
crucial implications. Paladin, which was previously classiﬁed as a phosphatase based on sequence
similarity, is expressed in chick neural crest precursors and is maintained throughout their epithelial to
mesenchymal transition and migration. Loss of Paladin delays the expression of transcription factors
Snail2 and Sox10 in premigratory neural crest cells, but does not affect accumulation of FoxD3, Cad6B or
RhoB, indicating that Paladin differentially modulates the expression of genes previously thought to be
coregulated within the neural crest gene regulatory network. Both gain and loss of Paladin function
result in disrupted neural crest migration, reinforcing the importance of precisely regulated phosphor-
ylation for neural crest migration. Mutation of critical, catalytic cysteine residues within Paladin’s
predicted phosphatase active site motifs did not abolish the function of Paladin in the neural crest.
Collectively, these data indicate that Paladin is an antiphosphatase that modulates the activity of
speciﬁc neural crest regulatory factors during neural crest development. Our work identiﬁes a novel
regulator of phosphorylation status that provides an additional layer of regulation in the neural crest.
& 2012 Elsevier Inc. All rights reserved.Introduction
Neural crest cells are a multipotent, migratory cell type that is
unique to vertebrate embryos. Neural crest precursors originate
as epithelial cells within the dorsal neural tube, then undergo an
epithelial to mesenchymal transition and delaminate from the
neural tube. Once motile, neural crest cells migrate to the
periphery and eventually differentiate into a variety of cell types,
including neurons and glia of the peripheral nervous system,
craniofacial bone and melanocytes (LeDouarin and Kalcheim,
1999).
While a gene regulatory network (GRN) of transcription factors
that regulate neural crest speciﬁcation has been established
(Betancur et al., 2010; Sauka-Spengler and Bronner-Fraser,
2008), cells of the dorsal neural tube are not uniquely fated to
give rise to neural crest cells (Collazo et al., 1993; Selleck and
Bronner-Fraser, 1995). In particular, expression of neural crest
transcription factors does not guarantee that a cell will migratell rights reserved.
ill).
ical Research, Level 4, Block E,
IC 3168, Australia.(Chizhikov and Millen, 2004b; Duband, 2006; Linker et al., 2000).
For example, dorsal neural tube cells co-express Snail2, a neural
crest marker, and Lmx1a, a roof plate marker, and become either
cell type (Chizhikov and Millen, 2004a). Because expression of
transcription factors that specify neural crest cell identity does
not ensure neural crest development, we postulate that modula-
tion of protein activity provides an additional layer of control
during neural crest development.
Phosphorylation is a well-established mechanism for regulat-
ing protein activity. A phosphate group is added to a serine,
threonine or tyrosine residue within the targeted protein by a
kinase, and the process is reversible through the activity of a
phosphatase (Sefton and Shenolikar, 2001). Phosphorylation
status is also regulated by a third class of proteins, the antipho-
sphatases, sometimes referred to as pseudophosphatases.
Antiphosphatases contain incomplete or divergent inactive
phosphatase domains and bind to phosphorylated residues on
target proteins to protect them from dephosphorylation (Cui
et al., 1998; Gingras et al., 2009; Wishart and Dixon, 1998). While
kinase and phosphatase inhibitor treatments show that phosphor-
ylation in general regulates neural crest adhesion and migration
(Brennan et al., 1999; Minichiello et al., 1999; Monier-Gavelle and
Duband, 1995; Newgreen and Minichiello, 1995), only recently
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A growing list of kinases active in neural crest cells (for example
Banerjee et al., 2011; Jin et al., 2012; Murphy et al., 2011; Ossipova
and Sokol, 2011) reinforces the idea that phosphorylation is
important for neural crest development. Meanwhile, mutation of
the phosphatase Shp2 was recently shown to cause abnormalities
in neural crest derivatives (Nakamura et al., 2009; Stewart et al.,
2010) while inhibition of PP2A phosphatase activity results in
increased cranial neural crest migration (Latta and Golding, 2012).
While target protein phosphorylation status can determine bio-
logical activity, for example phosphorylation of the neural crest
transcription factor Twist affects binding partner choice and
transcriptional outcome (Firulli and Conway, 2008), a neural crest
antiphosphatase that can sustain target phosphorylation has never
been described.
Paladin (Pald) is a protein that contains two phosphotyrosine
phosphatase consensus active site motifs but lacks other domains
characteristic of phosphatases. Found only in vertebrates, Pald
was ﬁrst identiﬁed in a large-scale cDNA sequencing project
(Nagase et al., 1999) and was subsequently identiﬁed in a screen
for genes upregulated as a consequence of neural crest induction
(Adams et al., 2008; Gammill and Bronner-Fraser, 2002). Recent
work has shown that Pald inhibits insulin-stimulated phosphor-
ylation of AKT; however, in vitro assays have failed to detect
phosphatase activity for Pald (Huang et al., 2009). As no in vivo
functional assays have assessed the importance of Pald’s phos-
phatase domains, it is unclear whether to categorize Pald as a
phosphatase or antiphosphatase (Alonso et al., 2004).
We have examined the role that Pald plays in chick neural
crest development. Pald is expressed in premigratory and migra-
tory neural crest cells, consistent with a role in the neural crest.
Loss of Pald results in reduced expression of some neural crest
transcription factors, but not others, indicating Pald differentially
regulates pathways in the neural crest GRN. Later in development,
both gain and loss of Pald result in disrupted neural crest
migration, indicating Pald levels are strictly regulated during
neural crest migration. Additionally, mutation of critical cysteines
in Pald’s putative phosphatase active site motifs does not abolish
Pald function. As these mutations should eliminate Pald activity if
it is a phosphatase, and because Pald does not exhibit phospha-
tase activity in vitro (Huang et al., 2009), we propose that Pald is
an antiphosphatase that regulates the phosphorylation and activ-
ity of target proteins during neural crest development.Materials and methods
Chicken embryo culture
Fertile chicken embryos were obtained from local sources and
incubated in a humidiﬁed incubator at 37–38 1C (G.Q.F. Manu-
facturing; Savannah, GA). Embryos were staged according to
Hamburger and Hamilton (1951) or by counting somite pairs.
Morpholinos and DNA constructs
FITC- or lissamine-tagged morpholinos (MOs) were obtained from
GeneTools, LLC (Philmouth, OR) with the following sequences:
translation blocking cPald MO TGCACGCTCTCAAAGGCGGAGGCTG;
5 bp mismatch control mmcPald MO TGgACcCTCTgAAAGcCGGAc
GCTG; splice blocking spcPald MO CAACAAGCAGCAATGCCAACCT
GCA; 5 bp mismatch control mmspcPald MO CAAgAAcCAcCAATcC-
CAACCTcCA. For overexpression, full-length Pald was subcloned using
standard methods into pMES (Swartz et al., 2001) with GFP replaced
with mcherry (pMES-mcherry) using PCR driven overlap extension
(Heckman and Pease, 2007). Phosphatase active site mutations weremade using a QuikChange II Site-Directed Mutagenesis Kit (Agilent;
Santa Clara, CA).
Electroporation
Embryos at HH stage 4–5 were electroporated with morpho-
lino and DNA as previously described (Gammill and Krull, 2011).
Morpholinos were used at 1.0 mM with or without DNA. DNA for
overexpression was electroporated at 1–5 mg/ml as indicated
along with 1.0 mM standard control MO. After electroporation,
embryos were reincubated to the appropriate stages, ﬁxed with
4% paraformaldehyde at RT for 1 h, and imaged using ﬂuorescent
microscopy. Embryos were screened for appropriately targeted,
bright MO incorporation prior to analysis because the MO
ﬂuorescent tag often does not persist after in situ hybridization.
Embryos were then dehydrated into methanol and stored at
201 C for in situ hybridization or embedded immediately for
sectioning.
In vitro translation
In vitro translation was performed using the FluoroTect
GreenLys in vitro Translation labeling system and Rabbit Reticu-
locyte Lysate (Promega; Madison, WI) according to the manufac-
turer’s instructions. Brieﬂy, full length chick Paladin, including 44
bp of 50 UTR, was cloned from a chick embryo expression library
(Gammill and Bronner-Fraser, 2002) and subcloned into
CS2þmyc (Turner and Weintraub, 1994). A construct containing
a 5 base pair mismatch in the morpholino target sequence
(mmcPald) was generated by PCR using primers containing the
mismatch target site. mRNA for Pald or mmcPald was in vitro
transcribed and used as template for in vitro translation. 0.5 mM
or 1.0 mM cPald MO was added to selected samples. Reactions
were run out on a 10% Tris–HCl SDS PAGE gel, and results
visualized on an FLA-5000 imager (FujiFilm; Stamford, CT). Band
intensity was measured and compared using Image Gauge soft-
ware (FujiFilm).
RT-PCR
Electroporated embryos were incubated to 6–8 somites. MO
targeted hemi-heads were dissected from these embryos and RNA
was isolated using Trizol (Life Technologies; Grand Island, NY)
and reverse transcribed using SuperScript III (Life Technologies;
Grand Island, NY) according to manufacturer’s instructions. cDNA
was then used as template for PCR reactions using Choice
Taq (Denville Scientiﬁc; Metuchen, NJ). No reverse transcriptase
samples were used as negative controls. Primer sequences
were as follows: Pald exon2 F-CCTGAGCATCCACTCCTTTC; Pald
exon4 R-GCTGACCCATACCAAACACC; GAPDH F-GGACACTTCAA-
GGGCACTGT; GAPDH R-TCTCCATGGTGGTGAAGACA.
In situ hybridization
Digoxigenin-labeled RNA probes were translated using the
following constructs as templates: Snail2 (Gammill and Bronner-
Fraser, 2002); Sox10 (Cheng et al., 2000); FoxD3 (Kos et al., 2001);
Cad6B (Gammill and Bronner-Fraser, 2002); RhoB (gift of Lisa
Taneyhill); Msx1 (clone ChEST900p21; Boardman et al., 2002);
and Sox2 (Uwanogho et al., 1995). In situ hybridization was
performed as described previously (Wilkinson, 1992). Embryos
were viewed in whole mount with a Zeiss Discovery V8 stereo-
scope and selected embryos were embedded and sectioned with a
Leica CM1900 cryostat at 10–20 mm and imaged on a Zeiss
AxioImager A1.
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Phenotype was evaluated at cranial axial levels well targeted
with ﬂuorescent MO signal. Effects on premigratory gene expres-
sion in whole mount were analyzed by comparing the relative
intensity of in situ hybridization colorimetric signal on the
targeted and untargeted sides of the embryo using the criteria
shown in Fig. S1. In section images, the cross-sectional area of the
expression domain on targeted and untargeted sides of the neural
tube were compared in ﬁve sections of selected embryos using
Image J (NIH). Effects on migration were scored by comparing the
distance migrated on targeted and untargeted sides using the
criteria shown in Fig. S1. Statistical analysis of phenotypic effects
was performed using Fisher’s exact test in R (R Development Core
Team, 2011).Immunostaining and cell counting
Embryos were inﬁltrated with 5% and 15% sucrose, embedded
in gelatin, frozen in liquid nitrogen and sectioned with a Leica
CM1900 cryostat at 10–20 mm. Sections were stained with anti-
HNK-1 (ATCC; Manassas, VA), anti-cleaved caspase3 (Cell Signal-
ing; Danvers, MA) or anti-phospho-Histone H3 (Millipore;
Billerica, MA) followed by the appropriate secondary antibody
(Cy2 anti-Mouse IgM or Cy5 anti-Rabbit, Jackson; West Grove, PA)
as indicated. Slides were mounted with PermaFluor (Thermo
Fisher Scientiﬁc; Waltham, MA) containing DAPI and viewed on
either a Zeiss AxioImager A1 or a Zeiss CARV spinning disk
confocal microscope. Images were adjusted in Photoshop (Adobe).
Nuclei and dividing or dying cells were counted in the dorsal
quarter of the cranial neural tube on both the targeted and
untargeted sides of the embryo for at least ﬁve sections per
embryo and statistics were performed in Excel (Microsoft).Results
Chick Paladin is expressed in premigratory and migratory neural
crest cells
In order to better understand early neural crest development,
previous work identiﬁed 176 genes that are upregulated as neural
crest cells are preparing to migrate (Adams et al., 2008; Gammill
and Bronner-Fraser, 2002). One of these genes, Paladin (incor-
rectly identiﬁed as Palladin in Gammill and Bronner-Fraser,
2002), is annotated as a putative phosphatase and its expression
proﬁle remains unreported. Chick Pald was expressed in premi-
gratory neural crest cells at 4 somites in cranial (Fig. 1B, open
arrowhead) and trunk domains (Fig. 1D, open arrowhead) as well
as along the basal surface of the neural tube (Fig. 1C and D, white
arrows). This expression persisted in cranial and trunk premigra-
tory neural crest precursors at 8 somites (Fig. 1G and H, arrow-
heads), indicating that Pald is expressed throughout premigratory
neural crest development.
Both cranial and trunk neural crest cells maintained expres-
sion of Pald as they delaminated from the neural tube (Fig. 1K and
M, closed arrowheads) and migrated away (Fig. 1F and J). Pald
mRNA expressing cells outside of the neural tube (Fig. 1J, arrow-
head) were conﬁrmed as neural crest cells by costaining with
HNK-1 (Fig. 1J0, arrowhead). Expression of Pald was still apparent
in migrating neural crest cells and their derivatives within the
branchial arches at 30 somites (Fig. 1L, arrowheads). Additionally,
Pald was expressed in otic placode and vesicle cells (Fig. 1C, E, G,
and I, o) as well as nascent blood vessels (Fig. 1H, black arrows).
Expression of Pald transcripts in neural crest cells at multiplestages puts Pald in the right time and place to regulate neural
crest development.
Paladin is required for premigratory expression of Snail2 and Sox10
but not other neural crest genes
We designed a translation blocking morpholino against chick Pald
(cPald MO) to examine the requirement for Pald during neural crest
development. To test the ability of this morpholino to inhibit
translation of PALD protein, we performed in vitro translation
reactions. Inclusion of cPald MO in the translation reaction resulted
in a dose-dependent decrease in the amount of PALD produced
(Fig. S2A). cPald MO was ineffective when 5 base pairs of the
morpholino target site were changed, indicating that cPald MO is
speciﬁc. We also utilized a second morpholino designed against the
splice donor site of intron 3 (spcPald MO). This morpholino altered
Pald mRNA splicing when assessed using RT-PCR (Fig. S2B).
To determine whether Pald regulates neural crest development in
chicken embryos, we electroporated the Pald MOs unilaterally into
neural crest precursors at mid-gastrula, during neural crest speciﬁca-
tion (Basch et al., 2006; Gammill and Krull, 2011). Electroporated
embryos were then analyzed for expression of Snail2 by in situ
hybridization in whole mount and transverse sections when neural
crest cells were still in the neural tube. Electroporation of a morpho-
lino with a 5 base pair mismatch (mmcPald MO) did not affect
premigratory expression of Snail2 on the targeted side of embryos
(Fig. 2A, asterisk; Fig. 2H, n¼18). However, knock down of Pald using
cPald MO resulted in a consistent decrease in the expression of Snail2
on the targeted side relative to the untargeted side of 68% of embryos
analyzed (Fig. 2B, asterisk; Fig. 2H, p¼1.1103, n¼19). A similar,
but slightly stronger effect was observed in 87% of embryos electro-
porated with spcPald MO (Fig. 2H, p¼1.1103, n¼15). Thus, Pald
is required for premigratory Snail2 expression in the neural crest.
To assess whether Pald regulates neural crest cell speciﬁcation
generally or Snail2 expression speciﬁcally, we examined premi-
gratory expression of other neural crest cell markers. While
effects on Sox10 expression were subtle in whole mounts
(Fig. 2C and D top), defects were apparent in sectioned embryos
(Fig. 2C and D bottom). 44% of mmspcPald MO electroporated
embryos displayed slightly decreased Sox10 expression (Fig. 2C
and H, n¼9), indicating that the morpholino is at the upper
limit of its effective- and speciﬁc-dose range (Moulton and Yan,
2008). Nevertheless, Sox10 expression was slightly to moderately
decreased in all embryos electroporated with spcPald MO,
with 44% exhibiting a moderate reduction (Fig. 2D and H,
p¼8.5103, n¼9). While both Snail2 and Sox10 are transcrip-
tion factors regulating neural crest cell fate, a third transcription
factor, FoxD3, was unaffected upon Pald knock down by either
cPald (n¼23) or spcPald (n¼14) MO (Fig. 2E and I). Furthermore,
two neural crest cell effector genes, RhoB (Fig. 2F and I) and the
epithelial cadherin Cad6B (Fig. 2G and I), were normally expressed
as well following Pald MO electroporation. Importantly, Cad6B
was downregulated on time in Pald-deﬁcient embryos (Fig. 2G).
Notably, neural and dorsal neural tube makers were also
expressed normally in Pald knock down embryos, revealing intact
patterning of neural tube fates (Fig. S3). As in the case of Snail2
expression, both MOs elicited similar phenotypes for all neural
crest markers analyzed (Fig. 2H and I). These results indicate that
Pald is required for expression of both Snail2 and Sox10, but not
for neural crest speciﬁcation generally.
Initial reductions in Snail2 and Sox10 transcripts could have
been caused by increased rates of cell death or decreased cell
proliferation in neural crest cells. To examine this possibility, we
electroporated embryos with mmspcPald MO or spcPald MO and
assessed cell proliferation and death markers in embryo sections
at premigratory neural crest cell stages. Quantiﬁcation of dying
Fig. 1. Paladin is expressed in premigratory and migratory neural crest cells. (A–D) Cranial (B and C), and trunk (D) premigratory neural crest cells (open arrowhead) express
PaldmRNA at 4 somites (4 s). (E–M) At 8 s (E–H), 10 s (I–K), and 30 s (L and M), Pald expression persists in hindbrain (G) and trunk premigratory neural crest cells (H, open
arrowheads) and is maintained during delamination and migration of midbrain (F, I, and J), hindbrain (K and L), and trunk neural crest cells (M; arrowheads). Pald
expressing cells (J, arrowhead) are positive by immunoﬂuorescence for the migratory neural crest marker HNK-1 (J0 , arrowhead), conﬁrming their identiﬁcation as neural
crest cells. Pald is also expressed in the basal surface of the neural tube (white arrows), blood vessels (black arrows), and dermomyotome (asterisk). (A, E, and I) dorsal
view; (L) dorsolateral view; (B–D, F–H, J, K, and M) transverse section at the level indicated in the accompanying whole mount. (I) Higher magniﬁcation view. Fg, foregut;
nt, neural tube; o, otic placode.
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mmspcPald MO nor spcPald MO altered rates of either cell death
or proliferation in the dorsal neural tube (Fig. S4). Similar results
were observed with cPald MO (data not shown). Thus Paladin
does not appear to regulate cell proliferation or death but
expression of particular neural crest genes speciﬁcally.
Neural crest migration is disrupted upon Paladin knock down
Because Pald was expressed throughout neural crest devel-
opment (Fig. 1), we wanted to determine if Paladin was also
required for neural crest migration. We again knocked downPald using unilateral morpholino electroporation at mid-gastrula,
but instead let embryos develop to 8 to 11 somites. When cranial
neural crest cells were visualized in these embryos by whole-
mount HNK-1 immunoﬂuorescence, we noted that migration of
cPaldMO-electroporated neural crest cells was curtailed (Fig. 3A,
arrowheads). To characterize this disruption, we performed Sox10
in situ hybridization, as Sox10 is a robust marker of neural crest
cells throughout their emigration and active migration (Cheng
et al., 2000), and because moderate levels of Sox10 expression
are retained in Pald knock down embryos (Fig. 2D). While a
minority of mmspcPald MO, mmcPald MO, and standard control
MO electroporated embryos exhibited slight migratory defects on
Fig. 2. Pald is required for premigratory expression of Snail2 and Sox10. Embryos were unilaterally electroporated at HH stage 4–5 with mmcPald MO (A), cPald MO (B, E, F,
and G), mmspcPald MO (C) or spcPald MO (D). After reincubation to 4–8 somites (s), in situ hybridization was performed to assess expression of Snail2 (A and B), Sox10
(C and D), FoxD3 (E), RhoB (F), or Cad6B (G). (A–D) Representative examples of Snail2 and Sox10 expression inhibition following Pald knock down. Snail2 expression is
unaffected in embryos electroporated with mmcPald MO (A) but reduced on the side of the neural tube targeted with cPald MO (B). Likewise, Sox10 expression is
unaffected in embryos electroporated with mmspcPald MO (C) but reduced on the side of the neural tube targeted with spcPald MO (D). (E–G) Representative examples of
neural crest regulators unaffected by Pald knock down. Expression of the transcription factor FoxD3 (E) and neural crest effector genes RhoB (F) and Cad6B (G) is equivalent
on cPaldMO targeted and untargeted sides of the neural tube. (H) Stacked bar graphs depicting the frequency and severity of Snail2 and Sox10 expression defects in
embryos electroporated with cPald MO, spcPald MO, mmcPald MO, mmspcPald MO, or control (co) MO when assayed in whole mount (Snail2) or sections (Sox10).
(I) Stacked bar graphs reveal the absence of FoxD3, Cad6B, and RhoB expression defects in nearly all embryos assayed. In (A–G), top row: dorsal views of in situ
hybridization in left panel, ﬂuorescent MO targeting in right panel; bottom row: transverse sections at the level of the midbrain. Note that the section shown is not
necessarily from the wholemount embryo pictured. Asterisk, targeted side of the embryo.
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cPald MO resulted in a slight to severe decrease in the distance
migrated on the targeted side compared to the untargeted side in
over 90% of embryos (Fig. 3C and F, spcPald MO p¼4.8104,
cPald MO p¼6.3105). Together, these results indicate that
Pald is required for proper neural crest migration.
As Sox10 is expressed at relatively normal levels in Pald knock
down embryos at migratory stages (compare Figs. 2D and 3C),
we determined whether Snail2 expression would also recover.Interestingly, when cPaldMO electroporated embryos were pro-
cessed by Snail2 in situ hybridization at early migratory stages,
elevated Snail2 expression was apparent in the targeted neural
fold (Fig. 3E and E0, asterisk). Moreover, cPaldMO-targeted migra-
tory neural crest cells expressed Snail2 at levels equivalent to
migratory neural crest cells on the untargeted side (Fig. 3E),
and once again revealed that Pald is required for neural crest
migration (Fig. 3F, p¼4.8103). As neural crest migration
progressed, Pald-deﬁcient neural crest cells appeared to ‘‘catch
Fig. 3. Loss of Pald impedes neural crest migration. Embryos were unilaterally electroporated at HH stage 4–5 with cPaldMO, mmspcPald MO, spcPald MO, or standard control MO
(coMO) and reincubated to 8–11 somites (s). (A) Neural crest migration defects visualized by HNK-1 immunoﬂuorescence following Pald knock down. cPald MO-targeted neural
crest cells (red; arrowheads) do not migrate as far as HNK-1 positive neural crest cells (green) on the untargeted side. (B and C) A representative example of neural crest migration
defects visualized by Sox10 in situ hybridization following Pald knock down. While mmspcPald MO does not affect neural crest migration (B), spcPald MO-targeted neural crest cells’
migration distance is reduced compared to the untargeted side (C). (D and E) A representative example of neural crest migration defects visualized by Snail2 in situ hybridization
following Pald knock down. While coMO does not affect neural crest migration (D), cPald MO-targeted neural crest cells’ migration distance is reduced compared to the untargeted
side. (E0) transverse section at the level of the line indicated in E. (B–E) Dorsal views of in situ hybridization in left panel, ﬂuorescent MO targeting in right panel. Asterisk, targeted
side of the embryo. (F) Stacked bar graphs depicting the severity and frequency of migration impairment in embryos electroporated with cPald MO, spcPald MO, mmcPald MO,
mmspcPald MO, or coMO and visualized by Sox10 (left) or Snail2 (right) in situ hybridization. Migration of neural crest cells is mildly disrupted by electroporation of mmspcPald MO,
indicating that 1.0 mM spcPald MO is the upper limit of its effective and speciﬁc dose.
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shown). These data suggest that absence of Snail2 is not preventing
neural crest migration, and that Pald is necessary to coordinate
early migration rather than active migration into the periphery.Excess Paladin impedes neural crest migration
Because loss of Pald disrupted neural crest migration, we next
wanted to examine the effects of Pald excess. To achieve this,
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pMES-mcherry. We electroporated pMES-Pald-mcherry DNA uni-
laterally into midgastrula stage embryos and assessed neural crest
cell migration. FITC-tagged control morpholino was included in
these electroporations because we ﬁnd coelectroporation of mor-
pholino along with DNA results in a higher efﬁciency of DNA
transfection and FITC ﬂuorescence is brighter than mcherry, allow-
ing for more accurate detection of properly transfected embryos.
Surprisingly, overexpression of Pald-mcherry at 5 mg/ml yielded a
decrease in neural crest migration distance (Fig. 4B and E,
p¼5.6105), similar to Pald knock down, whereas electroporation
of pMES-mcherry alone did not affect migration (Fig. 4A and E).
Importantly, the incidence and severity of Pald overexpression
defects was dose-dependent (data not shown). Pald overexpression
outside of the neural crest domain had no apparent effect, suggest-
ing Pald can affect active neural crest signaling pathways, but cannot
trigger their activation. These results indicate that both loss and gain
of Pald function disrupt neural crest migration, and Pald modulates
neural crest development but does not initiate it.Fig. 4. Pald overexpression disrupts neural crest migration. Embryos were unilaterally elec
1.0 mM FITC-labeled standard control MO (coMO). The MO served as a lineage tracer a
crest cells visualized by in situ hybridization for Sox10. (A–C) Representative embryo
migration is unaffected by pMES-mcherry electroporation (A), electroporation of Pald-m
migration on the targeted side. Dorsal views of in situ hybridization in left panel, ﬂuores
sequence. Phosphotyrosine phosphatase sites in yellow, active site cysteine is mutated
frequency of migration defects in embryos overexpressing either wildtype or phosphaMutation of Paladin’s protein tyrosine phosphatase domains does
not abolish Paladin function
While Paladin has been preliminarily classiﬁed as a protein
tyrosine phosphatase (PTP), little has been done to characterize
its biological function, likely because Pald does not exhibit
phosphatase activity in vitro (Huang et al., 2009). To examine
the activity of Pald, we assessed whether Pald’s PTP motifs were
essential for proper neural crest migration. Pald contains two core
PTP active site signature motifs, CX5R (Fig. 4D, Tonks, 2006), but
no other phosphatase accessory domains. Because the conserved
cysteine is critical for catalytic activity and phosphatase function
as it transiently accepts the phosphate during catalysis (Guan
and Dixon, 1991), we mutated both of Pald’s putative active site
cysteines (C285 and C648) to serines (Fig. 4D). With other
phosphatases, this strategy abolishes phosphatase activity, result-
ing in proteins that still recognize their substrates but no longer
dephosphorylate and release them; cysteine mutants are thus
called substrate-trapping mutations (Milarski et al., 1993).troporated at HH stage 4–5 with pMES-mcherry expression constructs mixed with
nd a carrier for the DNA. At 8–11 somites (s), embryos were harvested and neural
s showing inhibition of migration by Pald overexpression. Whereas neural crest
cherry (B) or C285/648S phosphatase domain mutant Pald (C) disrupts neural crest
cent MO in right panel. Asterisk, targeted side of the embryo. (D) Schematic of Pald
in both domains in C285/648S. (E) Stacked bar graphs depicting the severity and
tase mutant Pald.
Fig. 5. Phosphatase domain catalytic cysteine residues are not essential for Paladin activity in neural crest cells. Embryos were unilaterally electroporated at HH stage 4–5 with
spcPald MO mixed with pMES-mcherry vector DNA, pMES-Pald-mcherry or pMES-C285/648S-mcherry and reincubated. At 8–11 somites (s) embryos were harvested and
neural crest cells visualized by in situ hybridization for Sox10. (A–C) Representative examples of spcPald MO rescue. While neural crest migration is disrupted upon
unilateral coelectroporation of empty pMES-mcherry (A), neural crest cells migrate normally following coelectroporation of 5 mg/ml pMES-Pald-mcherry (B) or 5 mg/ml
C285/648S-mcherry (C). Dorsal views of in situ hybridization in left panel, ﬂuorescent MO in right panel. Asterisk, targeted side of the embryo. (D) Stacked bar graphs
depicting the severity and frequency of migration defects in embryos coelectroporated with spcPald MO and wildtype or phosphatase mutant Pald.
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mutations (C285/648S) would eliminate Pald function, whereas if
Pald was an antiphosphatase, Pald activity would be retained. Like
wildtype Pald, electroporation of C285/648S disrupted neural
crest migration (Fig. 4C and E, p¼0.016). The number of embryos
affected by C285/648S overexpression was not signiﬁcantly dif-
ferent compared to wildtype Pald overexpression (Fig. 4E,
p¼0.31), however, the phenotypic severity was decreased. These
data suggest that the conserved cysteines within the Pald PTP
catalytic domains are required for complete Pald activity in
regulating neural crest migration. However, because the migra-
tion disrupting activity of Pald was still intact, the active sites are
unlikely to confer phosphatase catalytic activity.
Paladin active site mutants rescue Paladin loss of function in neural
crest cells
To fully assess the biological activity of Pald during neural
crest development, we wanted to see if the C285/648S mutant
protein could substitute for endogenous Pald. First, we needed to
establish the ability of wildtype Pald to rescue spcPald MO
electroporated embryos. We coelectroporated spcPald MO with
varying amounts of Pald-mcherry DNA that is not targeted by
either MO. While some rescue was observed at 3 and 4 mg/ml
Pald-mcherry (data not shown), optimal rescue was observed at
5 mg/ml and further experiments were carried out at thisconcentration (Fig. 5B and D). Knock down of Pald using spcPald
MO once again disrupted neural crest migration by decreasing the
distance migrated in almost 90% of embryos (Fig. 5A and D),
whereas coelectroporation of spcPald MO with Pald-mcherry
resulted in normal migration in about 50% of embryos (Fig. 5B
and D, p¼0.039). These data indicate that disrupted neural crest
migration following spcPald MO electroporation is speciﬁcally
due to loss of Pald function, as replacement with exogenously
supplied Pald rescues this defect.
Next, to assess the importance of the putative active site
cysteines, we examined the ability of C285/648S to rescue spcPald
MO knock down. While overexpression of C285/648S suggested
that these cysteine residues, which are critical for function of a
phosphatase active site, are important for Pald function during
neural crest migration, we do not know the mechanism by which
overexpression prevents neural crest migration. Knocking down
endogenous Pald with spcPald MO and rescuing with C285/648S
provides a more direct test of the importance of the putative
active site cysteines. Following coelectroporation of spcPald MO
with C285/648S, about 50% of embryos exhibited normal neural
crest migration (Fig. 5C and D, p¼0.031). Although the proportion
of embryos rescued by wildtype or C285/648S coelectroporation
was similar and not signiﬁcantly different (Fig. 5D; p¼0.76),
those embryos that were affected exhibited more severe pheno-
types with C285/648S rescue than those rescued with wildtype
Pald. These results indicate that while putative active site cysteine
J. Roffers-Agarwal et al. / Developmental Biology 371 (2012) 180–190188residues are not essential for Pald function in the neural crest,
these residues are necessary for maximal Pald activity during
neural crest migration.Discussion
The function of Pald, which was presumed to be a phospha-
tase, was unknown during embryogenesis. Here, we show that
Pald is expressed in premigratory and migratory neural crest cells,
and that this expression is maintained in later neural crest
derivatives, suggesting that Pald plays a role throughout neural
crest development. Pald knock down demonstrates that Pald
affects premigratory Snail2 and Sox10 expression but not neural
crest speciﬁcation generally. Additionally, loss and gain of func-
tion analysis reveals that Pald regulates early neural crest migra-
tion. Finally, our mutational analysis reveals that protein tyrosine
phosphatase active site cysteine residues are not essential for Pald
activity, indicating that Pald is an antiphosphatase that binds and
protects phosphorylated residues during neural crest migration.
Paladin differentially affects members of the neural crest gene
regulatory network
Genes involved in the early stages of neural crest development
have been characterized in multiple species and their regulatory
interactions organized into a gene regulatory network (Betancur
et al., 2010). The neural crest speciﬁcation transcription factors
Snail2, Sox10, and FoxD3 are expressed in premigratory neural crest
cells and downregulated at various points once migration com-
mences. Two of these transcription factors, Snail2 and FoxD3, were
found to be activated by similar sets of genes, namely Msx1 (Tribulo
et al., 2003), Pax3/7 (Sato et al., 2005), and Hairy2 (Glavic et al., 2004;
Wettstein et al., 1997). Interestingly, loss of Pald in premigratory
neural crest cells results in differential effects on these genes with a
disruption in Snail2 expression (Fig. 2B and H) and no effect on
FoxD3 (Fig. 2E and I), indicating that these transcription factors have
differential regulation that has not been appreciated by neural crest
gene regulatory analysis to date. The third transcription factor,
Sox10, is expressed at a slightly later stage in development than
Snail2 and FoxD3 and its expression in premigratory neural crest
cells is also disrupted by loss of Pald, though to a lesser extent than
Snail2 (Fig. 2D and H). These data indicate that Pald selectively
impacts neural crest transcription factor expression.
One potential explanation for this differential effect on neural
crest transcription factors is that Pald directly regulates Snail2
expression. Interestingly, SNAIL2 is a highly unstable protein in
neural crest cells (Vernon and LaBonne, 2006) and in cancer cells,
Snail stability is inﬂuenced by phosphorylation (Zhou et al., 2004).
Furthermore, Snail positively autoregulates its own expression
(Fuse et al., 1996). Nevertheless, we were unable to detect an
interaction between PALD and SNAIL2 using directed yeast-two
hybrid (data not shown). This implies that Pald does not directly
regulate Snail2 expression by modulating SNAIL2’s phosphoryla-
tion status, and instead that Pald modulates a protein that
regulates Snail2 but not FoxD3 expression. Efforts to identify such
a target of Pald are currently underway.
Examination of neural crest effector genes upon Pald knock
down also revealed novel insights into previously characterized
neural crest gene regulatory interactions. Cellular effectors of
neural crest development act subsequent to neural crest tran-
scription factor expression, promoting delamination and migra-
tion. RhoB activity is required for delamination from the neural
tube (Liu and Jessell, 1998) and its expression was unaffected by
Pald knock down (Fig. 2F and I). Cad6b is an epithelial cadherin
whose expression is directly downregulated in cranial neuralcrest cells by Snail2 prior to delamination (Taneyhill et al.,
2007). Interestingly, though Snail2 expression is disrupted in
premigratory neural crest cells, we did not observe a delay in
the downregulation of Cad6b transcripts as we would have
expected given their direct regulatory relationship (Fig. 2G and
I). This unexpected result reveals that regulation of Cad6b expres-
sion can be uncoupled from Snail2, indicating that Cad6B tran-
scriptional regulation is more complex than currently appreciated
and warrants additional characterization. Altogether, our data
reveal that Pald is required for expression of speciﬁc neural crest
regulatory genes, but not neural crest speciﬁcation in general.
Paladin regulates but is not essential for neural crest migration
Our data indicate that either loss or gain of Pald disrupts neural
crest migration. Analysis during early stages of neural crest migration
shows a decreased migration distance upon overexpression (Fig. 4B)
or knock down (Fig. 3A, C, and E). However, when these embryos are
allowed to develop to later stages, neural crest migration recovers
(data not shown), indicating that migration is disrupted but not
prevented by loss or gain of Pald. Interpretation of knock down effects
is complex: because embryos were electroporated with morpholino
at mid-gastrula stages, migration defects (Fig. 3) could be a secondary
consequence of earlier effects on neural crest gene expression during
speciﬁcation (Fig. 2). Unfortunately we could not separate the role of
Pald in premigratory and migratory neural crest development by
timed electroporation as electroporation of Pald MOs later than HH
stage 5 had no phenotype (data not shown). Given this is quite an
early stage, we presume that Pald is a stable protein that accumulates
to sufﬁcient levels for normal development by stage 5. Nevertheless,
three observations argue that Pald regulates migration directly. First
of all, Snail2 and Sox10 expression in neural crest cells recovers by
migratory stages although migration is still impaired (Fig. 3). This
suggests speciﬁcation defects are not preventing migration. Second,
migration is more severely affected than speciﬁcation following Pald
knock down (compare Figs. 2H and 3F), suggesting these outcomes
are independent. Third, following Pald knock down Cad6B down-
regulates on schedule and RhoB is expressed normally, suggesting
there is not a general block to neural crest development, but that
speciﬁc regulators of speciﬁcation and migration are affected. Impor-
tantly, temporally normal expression of Cad6B and RhoB also suggests
that Pald targets likely do not include factors that regulate epithelial
to mesenchymal transition. Taken together, these results suggest that
Pald regulates early migration away from the neural tube, but its
function is not critical for emigration and active migration into the
periphery.
It is surprising that we observed similar phenotypes upon
overexpression and knock down of Pald. One explanation is that
providing excess Pald causes it to be mislocalized and/or abnor-
mally sequestered within a cell, removing it from its normal site
of action and effectively causing a Pald loss of function pheno-
type. Another possibility is that a precise level of Pald is necessary
to maintain the correct balance of target protein phosphorylation/
dephosphorylation necessary for proper function. In other words,
target dephosphorylation (absence of Pald, phosphorylated sites
unprotected) and target hyperphosphorylation (excess of Pald,
sites always phosphorylated) might equally prevent normal
target protein activity and thus elicit the same phenotype.
Classiﬁcation of Paladin as an antiphosphatase
Determining the mechanism by which Pald regulates neural
crest development is difﬁcult without knowing its biological
activity. While Pald contains two core catalytic protein tyrosine
phosphatase (PTP) active site motifs (CX5R, Fig. 4D; Alonso et al.,






































A Model for Paladin’s Biological Activity
Fig. 6. A model for Paladin’s role in neural crest development. (A) Predicted
mechanism of Paladin’s biological activity. A Paladin target protein (orange oval)
is tyrosine-phosphorylated (dark pink P) during neural crest development. Paladin
(blue star) binds to the phosphotyrosine, protecting it from removal by phospha-
tases (turquoise hexagon) and sustaining target protein activity. (B) In a C285/
648S Paladin mutant, we predict that the loss of the critical cysteine reduces the
afﬁnity or speciﬁcity of mutant Paladin (light blue star) for the target phospho-
tyrosine, making protection from dephosphorylation less efﬁcient (light pink P).
We predict that expression of C285/648S mutant Paladin results in partial
dephosphorylation of target protein(s), which we expect would lead to a slight
decrease in Snail2 and Sox10 as well as the observed mild disruption of neural
crest migration and less effective rescue. (C) Paladin knock down results in
unprotected target phosphotyrosines, allowing for dephosphorylation by a phos-
phatase. This alters target protein activity which impedes Snail2 and Sox10
expression and disrupts early phases of neural crest migration.
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tase activity, namely the majority of the 280 amino acid extended
catalytic domain (Tonks, 2006). For these reasons Pald is fre-
quently cited as an example of a divergent tyrosine phosphatase
family member. Alternatively, antiphosphatases contain catalyti-
cally inactive PTP domains with altered critical catalytic residues
(Alonso et al., 2004). Although the core phosphatase motifs are
intact in Paladin, Pald does not exhibit phosphatase activity
in vitro (Huang et al., 2009), increasing our suspicion that Pald
may instead be an antiphosphatase.
Mutation of a PTP domain by substituting the active site cysteine
with a serine inactivates tyrosine phosphatases (Fauman and Saper,
1996) and leads to sustained interactions between a phosphatase and
its targets (Flint et al., 1997). We predicted that if Pald is a
phosphatase, the cysteine to serine mutation would abolish Paladin
function, whereas if Pald is an antiphosphatase the mutation would
affect Pald activity minimally, if at all. Overexpression of either
wildtype or C285/648S Pald disrupts neural crest migration without
any statistically signiﬁcant difference in the phenotypic outcome
(Fig. 4B, C, and E). Furthermore, C285/648S is able to rescue Pald
knock down embryos (Fig. 5C and D), indicating the mutation does
not abolish Pald activity and implying that Pald is an antiphosphatase.
Because the overall proportion of embryos affected by Pald over-
expression and C285/648S overexpression is similar with a slight
reduction in severity of phenotypes observed (Fig. 4E), and while
C285/648S is equally efﬁcient at rescuing Pald knock down with a
slight increase in the severity of those affected (Fig. 5D), we conclude
that PTP cysteine residues are required for optimal Pald activity.
Because we deduce that Pald is an antiphosphatase, this suggests
that regulation of the phosphorylation status of Pald target proteins is
required for expression of Snail2 and Sox10 during neural crest
development. Due to the ability of antiphosphatases to bind to their
phosphorylated targets and protect them from dephosphorylation,
and the fact that phosphorylation is a known regulator of protein
activity, we postulate that Pald acts a signal enhancer to reinforce the
activity of phosphorylated target proteins that are necessary for
neural crest speciﬁcation and early steps in migration. The end result
is that, although neural crest cells will eventually migrate without
Pald activity, expression of Pald prolongs the intensity and duration of
regulatory factor activation to promote/expedite early neural crest
development. This hypothesis is supported by the fact that ectopic
Pald can only affect neural crest development within the neural crest-
forming domain: Pald can only exert its effects when target proteins
are already phosphorylated, and Pald itself cannot initiate neural crest
formation (Fig. 4B). Further work is needed to identify Pald targets to
fully explain the mechanism whereby Pald regulates neural crest
development.
A model for Paladin’s role in neural crest development
Based on the effects of Pald gain and loss of function, and the
consequences of cysteine active site mutations, we propose that Pald
is an antiphosphatase. Given that changes in phosphorylation state
are essential for proper neural crest migration (Minichiello et al.,
1999; Monier-Gavelle and Duband, 1995; Newgreen and Minichiello,
1995), we hypothesize that speciﬁc neural crest regulatory proteins
are phosphorylated and that this phosphorylation status either
positively or negatively affects protein activity during neural crest
development depending on the identity of the protein. According to
our working model, Pald binds to these phosphorylated proteins,
protects their phosphotyrosine residues from dephosphorylation and
sustains the activity necessary for proper neural crest gene expression
and subsequent migration (Fig. 6A). When Pald phosphatase domain
active site cysteines are mutated to serines in C285/648S, the mutant
protein does not protect its phosphorylated targets as well as wild-
type Pald. This results in less stable phosphorylation and alteredactivity of these targets, leading to mild effects on migration and, we
predict, gene expression (Fig. 6B). Pald loss of function results in
dephosphorylation of Pald targets, which leads to a reduction in both
Snail2 and, to a lesser extent, Sox10, as well as disrupted neural crest
migration (Fig. 6C). Future identiﬁcation of Pald targets and examina-
tion of their phospho-regulation within premigratory and migratory
neural crest cells will shed light on an understudied mechanism to
regulate neural crest development.Acknowledgments
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